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Abstract
Background: Cambodia is among the 22 high-burden TB countries, and has one of the highest rates of TB in
South-East Asia. This study aimed to describe the genetic diversity among clinical Mycobacterium tuberculosis
complex (MTC) isolates collected in Cambodia and to relate these findings to genetic diversity data from
neighboring countries.
Methods: We characterized by 24 VNTR loci genotyping and spoligotyping 105 Mycobacterium tuberculosis clinical
isolates collected between 2007 and 2008 in the region of Phnom-Penh, Cambodia, enriched in multidrug-resistant
(MDR) isolates (n = 33).
Results: Classical spoligotyping confirmed that the East-African Indian (EAI) lineage is highly prevalent in this area
(60%-68% respectively in whole sample and among non-MDR isolates). Beijing lineage is also largely represented
(30% in whole sample, 21% among non-MDR isolates, OR = 4.51, CI95% [1.77, 11.51]) whereas CAS lineage was
absent. The 24 loci MIRU-VNTR typing scheme distinguished 90 patterns with only 13 multi-isolates clusters
covering 28 isolates. The clustering of EAI strains could be achieved with only 8 VNTR combined with
spoligotyping, which could serve as a performing, easy and cheap genotyping standard for this family. Extended
spoligotyping suggested relatedness of some unclassified “T1 ancestors” or “Manu” isolates with modern strains
and provided finer resolution.
Conclusions: The genetic diversity of MTC in Cambodia is driven by the EAI and the Beijing families. We validate
the usefulness of the extended spoligotyping format in combination with 8 VNTR for EAI isolates in this region.
Background
Tuberculosis (TB) as caused by Mycobacterium tubercu-
losis complex (MTC) is one of the most important public
health problems in the world. In 2008, WHO estimated
9.4 million incident cases of TB, 11.1 million prevalent
cases, 1.3 million deaths among HIV-negative people and
an additional 0.52 million TB deaths among HIV-positive
people [1]. The largest number of new TB cases occurs
in the South-East Asian Region, that accounted for 34%
of incident cases in 2006 [2].
Cambodia is among the 22 high-burden TB countries,
and has one of the highest rates of TB in South-East
Asia [3]. The population of Cambodia is 13.4 million
(Population Census of 2008). The new sputum smear
positivity rate for Cambodia is estimated to be 220/
100,000 inhabitants whereas the TB incidence is esti-
mated around 500/100,000 inhabitants per year and the
mortality rate at 94/100,000 inhabitants [4]. Phnom-
Penh is the capital of Cambodia, with more than 1.3 mil-
lion inhabitants (Population Census of 2008), which
represents 10% of the whole population living in
the country. The population density of Phnom-Penh is
the highest of the country, with around 4,500 people
per km
2.
Except for studies done in neighboring countries
(Vietnam, Thailand and Myanmar) nothing is known
about the genetic diversity of MTC in Cambodia [5-7].
The goal of this study was to describe the genetic diver-
sity of MTC in Cambodia.
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aspect of tuberculosis control [8,9]. A high level of resis-
tance to Isoniazid (Inh) and Rifampin (Rif) was identi-
fied in Phnom Penh in patients co-infected with HIV,
and the minimal number ofM D R - T Bi d e n t i f i e dn e w
cases in 2009 in Cambodia was 94 [4].
We focused on a restricted population sample (n =
118), mixing randomly drawn (n = 59) and enriched in
MDR-TB clinical isolates (n = 59) according to drug
susceptibility testing results. We report in this article
the characterization of this 118 clinical isolates collec-
tion as a first insight on the genetic population structure
of MTC in Cambodia.
Results
Spoligotyping, classical 43 spacers format
M. tuberculosis complex clinical isolates were collected
from 118 patients. DNA samples were extracted from
subcultures by a thermolysis procedure. Patient demo-
graphic characteristics were as follows: a median age
of 38 years, and a sex ratio close to 1 (Table 1). We
obtained a 43-spacers spoligotyping result for 113 DNA
samples. A total of 42 individual patterns were found,
among which, 27 patterns were unique whereas 85 clini-
cal isolates were distributed in 15 clusters containing 2 to
31 isolates (Table 2). Eighteen patterns were not pre-
viously reported in the SpolDB4 international database
fifteen of which presenting the typical signature of
the East African-Indian (EAI) family (absence of spacers
29-32, presence of spacer 33, absence of spacer 34) [10].
Two other previously unreported isolates (isolates
Cam108 and Cam116) carried a T1-ancestor or “Manu”
signature (all spacers present except 33 and/or 34) and
one isolate harbored a very unusual pattern (spacer 1-3
only were present) [11]. Altogether, EAI is clearly the
predominant genetic family in Cambodia. It totaled 67
clinical isolates (59% of successfully genotyped isolates)
but up to 56 of the 84 successfully typed non-MDR
(67%). The Beijing family encompassed 34 isolates, (30%
of the total successfully genotyped isolates) but only 18
of non-MDR typed isolates (21%). In Beijing lineage, 26
out of 34 (76%) isolates were resistant to at least one of
the drug (isoniazid, rifampin, streptomycin, ethambutol)
while only 34% were among EAI isolates. The weight of
these two lineages significantly differed between non-
MDR and MDR isolates (OR = 4.52; CI95% [1.78,11.51]).
Other minor families were: the T (Modern) family (with
a total of 7 clinical isolates or 6%), some U (unclassified
with likely “T1-ancestor” or “Manu” signatures) patterns
(4 clinical isolates or 3.5%) and 3 other undefined iso-
lates, all together representing only ∼10% of total isolates.
Spoligotyping, extended 68 spacers format
The use of 25 additional spacers significantly improved
the discriminatory power. 51 patterns (+21%) were dis-
tinguished among which 36 were unique patterns. 77 iso-
lates were distributed in a total of 15 clusters (Table 2).
In the Beijing family (Spoligotyping-International-Type,
SIT1), 2 subtypes were observed, among which, one clus-
ter of only 2 isolates. Within the EAI family, several sub-
types were observed by 68 spacers’ spoligotyping (see
Additional file 1 and Figure 1). Among the predominant
clusters, two SIT signatures (SIT459, SIT204) were found
to be prevalent and each split into two subtypes. Geno-
typing with the 25 extra spacers revealed that the
“T1-ancestor” or “Manu” isolates all harbored the same
signature (absence of spacers 54-61) as do isolates from
Principal Genetic Groups 2 and 3 modern isolates. The
common ancestry of these “T1 ancestor” or “Manu” iso-
lates with the “Latin-American and Mediterranean
(LAM), the “Haarlem” (H), the “Anglo-Saxon” (X), other
less-defined “T-related” and some U (unknown) isolates
is further supported by their clustering based on MLVA
genotyping (see below and Figure 1).
MIRU-VNTR (Multiple Locus VNTR or MLVA) Typing
Hundred and five (105) clinical isolates out of 118 gave
interpretable results. QuB26 failure rate was the highest
(no amplification for 10 isolates); for three isolates, we had
no amplification of Qub4156 and for three others we had
no amplification of Mtub21. For some isolates a single
VNTR was missing. The 24 loci internationally-agreed
MIRU-VNTR typing scheme allowed to distinguish 13
clusters totaling 28 isolates (Table 2). Three isolates
(Cam001, Cam033 and Cam042) which were unclassified
by spoligotyping were similar to EAI isolates by MIRU-
VNTR. In particular, isolate Cam033 (SIT405) differed by
a single locus variation (SLV in MIRU02) from isolate
Cam038 which belongs to the EAI2_Manilla subfamily.
The discriminatory powers of each MIRU-VNTR locus
r e s p e c t i v e l yf o rt h ew h o l es a m p l ea n df o rE A Io rB e i j i n g
lineage were estimated by calculating the Hunter and Gas-
ton Discriminatory Index (HGDI) (Table 3). Nine loci
included in the standardized 24 VNTR scheme were unin-
formative to genotype Beijing clinical isolates. For Beijing
isolates, the most discriminatory loci were (in a decreasing
Table 1 Characteristics of the 118 patients
Age, y
Median (range) 38 (9-77)
Sex, n° (%)
Male 58 (50.9)
Female 56 (49.1)
Consultation in hospital in, n° (%)
Phnom Penh 81 (68.6)
Province 37 (31.4)
Multidrug resistant strains, n° (%) 33 (28.0)
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Page 2 of 7order): QuB26, MIRU10, MIRU16, Mtub04, Mtub21 and
QuB11b. Using these 6 loci, only 2 strains remained clus-
tered. For the EAI isolates of MTC, the most discrimina-
tory loci were (in a decreasing order): ETRD, Mtub39,
ETRA, Mtub21, ETRB and QuB26.
Combined Spoligotyping (68 spacers) and MIRU-VNTR
analysis
The number of clusters (defined as 100% identical isolates
on both 24 VNTR and spoligotyping) was low (n = 12)
and represented a total of 26 clinical isolates (Figure 1).
Among these clusters, a single cluster of 4 clinical isolates
(SIT48) was observed, whereas all others were micro-
clusters of 2 clinical isolates. Interestingly, two of these
microclusters were formed of MDR Beijing isolates.
The most prevalent Spoligo-International-Types (SIT)
were SIT204 and SIT459, both belonging to the EAI
family. They were searched for in the genetic databases
SITVIT2 http://www.pasteur-guadeloupe.fr and MIRU-
VNTRplus to look for the geographical distribution of
these two types [12,13]. The search within SITVIT2 of
SIT204 (737777777413771), retrieved six clinical isolates
Table 2 Discriminatory powers of the different genotyping methods, for the whole sample and for the two major
families
Method Strains Types Clusters Cluster size HGDI* HGDI EAI HGDI Beijing
MIRU-VNTR 24 loci 105 92 13 2-4 0,997 0,994 0,991
spoligotyping 68 spacers 113 51 15 2-29 0,925 0,963 0,229
spoligotyping 43 spacers 113 42 15 2-31 0,906 0,932 0,119
HGI = Hunter and Gaston Discriminatory Index.
MIRU-VNTR (MLVA)                                                      Spoligotype 68 spacers
Figure 1 Genotyping results and dendrogram of Cambodian Mycobacterium tuberculosis clinical isolates. From left to right: 1) UPGMA
dendrogram of the 105 genotypes obtained on 24 MIRU-VNTR loci (M. tuberculosis MLVA standard). 2) Number of repetitions of each VNTR
according to Supply et al. nomenclature. 3) 68-spacers Spoligotypes: black spots represent the presence and white spots represent the absence
of 1-68 spacer (according to J. van Embden et al. numbering [27]. 4) Strain number (internal nomenclature). 5) SIT = Spoligo-International-Type.
6) Genetic family (clade) according to SpolDB4 [38].
Zhang et al. BMC Infectious Diseases 2011, 11:42
http://www.biomedcentral.com/1471-2334/11/42
Page 3 of 7among which two were from patients living in neighbor-
ing Vietnam and Thailand. No similar isolates were
found in MIRU-VNTR plus database. The search within
SITVIT2 of SIT459 (777777777410331) retrieved three
clinical isolates (from France and USA) without more
information on the origin of patients. In MIRU-VNTR
plus database, a 4 loci strain variant (12778/03) was
found for this SIT. This MIRU-VNTR plus database iso-
late harbored SIT152, which differs by a single spacer
from SIT139, the prototypic spoligotype from the
“Hanoi strain” (also designated as EAI4_Vietnam) [10].
This confirms the relatedness to EAI lineage of the
SIT459 isolates included in our study.
By using the 68 spacer spoligotyping scheme and simul-
taneously the 6 most discriminant loci for EAI isolates
(ETRD, Mtub39, ETRA, Mtub21, ETRB and QuB26), we
obtained almost the same clustering result as by using the
24 VNTR loci. Only two clusters of two EAI isolates were
not distinguished using this combined scheme: isolates
Cam111 and Cam118 that differ by MIRU40 only, and iso-
lates Cam79 and Cam102 that differ by QuB11b only.
Considering that isolates that differ by a single marker
using MLVA-24 have an equal likelihood to represent a
non epidemiologically-informative cluster as an epidemio-
logically one (due to genetic convergence on MIRU-
VNTR), we suggest that these 6 VNTR loci combined to
spoligotyping scheme could be sufficient to genotype EAI
strains in this part of the world for epidemiological pur-
poses. Including two additional markers (MIRU40 and
QuB11b), i.e. 8 VNTR loci could further strengthen the
clustering results.
Discussion
This study provides for the first time an insight on the
genetic diversity of Mycobacterium tuberculosis complex
in Cambodia. Although preliminary because our sam-
pling was a mixed susceptible, mono-resistant, and MDR
clinical isolates and did not cover a sufficient period of
time and sufficient clinical isolates number, we show that
the population structure of M. tuberculosis in Cambodia
is dominated by the EAI and Beijing families and is
depleted of the Central Asian (CAS) family. Indeed, these
two families represent almost 90% of the total population
(59-67% for EAI and 21-30% for Beijing depending
whether the full set or the susceptible set only is taken to
be representative of the actual diversity). Other modern
families like T, Haarlem and Latin-American and Medi-
terranean (LAM) represent anecdotal cases.
Compared to previous studies performed in the South
and South-East Asian region (India, Bangladesh, Myan-
mar, Thailand, Vietnam and this study) we observe that
the CAS lineage is totally absent in Cambodia and Viet-
nam only [6,7,9,14-16]. Indonesia and Malaysia seem to
be the lower south-eastern borders of the CAS lineage
distribution in South-East Asia. Conversely an increased
gradient of the EAI lineage from to India to South-East
Asia is observed (Bangladesh: EAI, 27%; CAS, 16%, Beij-
ing, 33%; Myanmar: EAI, 48%; CAS, 5%, Beijing 32%;
Vietnam: EAI, 51%, Beijing, 32%; Cambodia: EAI, 60%,
Beijing 30%). In India, where the relative CAS/EAI dis-
tribution remains to be studied with more accuracy in
relation to human populations, it was shown that the
CAS lineage is predominant in the North (56%) and
sporadic in the South (1%) while the EAI lineage pro-
portion increases from 27% in the North to 89% in the
South [17].
The MDR-TB clinical isolates were shown to belong to
three lineages: Beijing, EAI and “T1-ancestor” also desig-
nated as “Manu”. The distribution of non-MDR and
MDR-TB clinical isolates within the lineages was signifi-
cantly different: whereas Beijing strains represented only
21% of non-MDR isolates, this percentage increased to
around 50% among MDR-TB clinical isolates. We also
observed two Beijing clusters which contained two per-
fectly identical MDR-clinical isolates each, whereas no
such cases were found among EAI MDR strains. With
the available data, the hypothesis of MDR-TB transmis-
sion could not be rejected. Drug-resistance thus could be
associated with Beijing family as already observed in Viet-
nam, Thailand and South Africa [6,9,18-22]. The exact
features of MDR-TB in this region clearly warrant further
studies.
Another goal of this study was also to investigate the
discriminatory power of alternative future genotyping
Table 3 Hunter Gaston Discriminatory Index (HGDI) of each locus of Multiple Loci VNTR Analysis (MLVA) for the whole
sample and for the two major families
ETRA ETRB ETRC ETRD ETRE MIRU02 MIRU10 MIRU16 MIRU20 MIRU23 MIRU24 MIRU26
Total 0,67 0,68 0,14 0,79 0,40 0,04 0,62 0,57 0,06 0,27 0,49 0,52
EAI 0,73 0,56 0,23 0,73 0,38 0,03 0,24 0,18 0,06 0,38 0,03 0,03
Beijing 0,07 0,00 0,00 0,13 0,13 0,00 0,51 0,50 0,00 0,00 0,00 0,37
MIRU27 MIRU39 MIRU40 Mtub04 Mtub21 Mtub29 Mtub30 Mtub34 Mtub39 Qub11b Qub26 Qub4156
Total 0,27 0,24 0,38 0,60 0,65 0,47 0,41 0,02 0,77 0,62 0,69 0,45
EAI 0,18 0,12 0,30 0,25 0,62 0,03 0,00 0,00 0,66 0,30 0,53 0,03
Beijing 0,33 0,30 0,34 0,47 0,45 0,00 0,00 0,00 0,13 0,40 0,59 0,28
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(MLVA) is actually the most powerful genotyping method
for M. tuberculosis, it has some technical limitations: in
lower resource countries, MIRU-VNTR can be only per-
formed manually. As these countries have often a high TB
prevalence, the work can be very time-consuming and
tedious. 24 VNTR typing may also be run on capillary
electrophoresis thus achieving higher efficiency. Spoligo-
typing is a first-line rapid genotyping method, even when
performed on membrane since it can analyze up to 40
samples per experiment in one day. When combined with
few highly discriminatory VNTR loci, spoligotyping can
achieve a discriminatory power similar to that obtained
with the 24-VNTR scheme, with much less working load
and time. In this study, a combination of spoligotyping
with 8 VNTR loci (ETRD, Mtub39, ETRA, Mtub21,
ETRB, QuB26, MIRU40 and QuB11b) allows to obtain the
same discriminatory power than the MIRU-VNTR 24 loci-
scheme for EAI strains (66 isolates). Thus, typing scheme
in Myanmar, Bangladesh, Laos and Cambodia could con-
sist in spoligotyping to identify main families, followed by
a restricted 8-VNTR panel for EAI isolates, while the
24 VNTR panel would remain mandatory for the remain-
ing MTC clinical isolates.
Conclusions
This study describes TB genetic diversity in Cambodia
and preliminary information on drug-resistance features
in this country. Our results support the absence of CAS
family such as in Vietnam.
Methods
Patient Characteristics
Samples were collected from January 2007 to October
2008 from inpatients and outpatients consulting in
Phnom Penh and in provincial hospitals. Strains were
obtained from fresh material: sputum (n = 93), broncho-
aspirates (n = 5), stool (n = 5), gastric aspirates (n = 3),
lymph node aspirates (n = 3), cerebrospinal fluid (n = 2),
urine (n = 1), blood culture (n = 1) and other (n = 5).
The characteristics of the 118 patients are shown in
Table 1. The mean age of the patients is 37.66 years.
58 men and 56 women, the male to female ratio equal to
1.03, slightly higher than the sex ratio of the region of
Phnom-Penh (0.9) (no information for 4 patients).
Mycobacterium tuberculosis isolation and identification,
drug susceptibility patterns
No formal informed consent was obtained for this study
since the study involved clinical isolates obtained during
routine diagnostic work. Sputum decontamination was
performed by the sodium-lauryl-sulfate method with
direct examination by the auramine technique followed by
culture on Löwenstein-Jensen and classical identification
using the niacin test [23]. First-line drug susceptibility
testing was done in BBL MGIT tubes (Becton Dickinson,
New Jersey, USA) with appropriate fluorescence detection
using the manual technique.
Clinical isolates and Drug Susceptibility testing patterns
118 clinical isolates of M. tuberculosis from the collec-
tion of Institut Pasteur of Cambodia were selected for
this study. All samples were isolated during 2007 to
2008 in the region of the capital city Phnom-Penh (n =
81) as well as from Kampong Cham (n = 25), Takéo
(n = 8), and others (n = 4, Siem Reap and Sihanouk
Ville). The whole sample results from the addition of
one totally random (n = 59) from 2007 and one collec-
tion enriched in MDR strains from both 2007 and 2008
(n = 59, nMDR = 31) as evidenced by their drug-suscept-
ibility testing profiles. The whole sample contained 59
strains (50%) which were susceptible for all 4 drugs
tested (Rifampin or Rif, Isoniazid or Inh, Streptomycin
or Srm and Ethambutol or Emb). 47 clinical isolates
were resistant to isoniazid, 43 were resistant to strepto-
mycin, 34 were resistant to rifampin, and 14 resistant to
ethambutol. 33 clinical isolates were MDR strains (28%),
12 of which isolated during 2007 and 21 isolated during
2008. 12 clinical isolates were resistant to all tested four
first line drugs.
DNA extraction method
MTC Colonies were scraped from LJ slopes, collected
into Eppendorf tubes containing Tris-EDTA buffer
(10 mM-1 mM, pH 8.0), heated for 30 min at 95°C and
freeze in ethanol-dry ice bath. After centrifugation at
13000 g, the resulting aqueous phase was transfered to
new tubes and kept at -20°C until further use.
Genotyping Methods
DNAs were sent by express carrier to the Institut Pas-
teur and an aliquot was transferred to the Institut of
Genetics and Microbiology to be genotyped. Both spoli-
gotyping and MIRU-VNTR were used as standard geno-
typing procedures.
Spoligotyping: The PCR was performed according to
the described protocol with a total of 20 cycles [24].
Spoligotyping was performed by using the microbeads-
based platform Luminex
® 200 [25,26]. In addition to the
classical 43 spacers’ spoligotyping, an extended spoligo-
typing assay with 68 spacers, using 25 extra spacers was
performed [27,28]. Family assignations were performed
by searching in SpolDB4 database [10]. The correspond-
ing naming was used. For a reminder, EAI is sometimes
called “Indo-Oceanic"; Beijing, “East-Asian"; CAS, “East-
African-Indian"; and modern Principal Genetic Group 2
and 3 strains, “Euro-American lineage” [29].
MIRU-VNTR typing (also called Multi-Locus VNTR
analysis or MLVA) was done as described previously
Zhang et al. BMC Infectious Diseases 2011, 11:42
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[30]. Loci analyzed were as follows; the 5 ETRs (exact
tandem repeats), ETRA, B, C, D, E [31]. The 12 MIRUs
(Mycobacterial Interspersed Repetitive Unit), MIRU-2, 4,
10, 16, 20, 23, 26, 27, 31, 37, 39, 40 (except for the
redundant ETR-D and ETR-E, i.e. MIRU- 4 and MIRU
-31 which were not retyped) [32,33]. The 6 Mtubs:
M t u b - 4 ,2 1 ,2 9 ,3 0 ,3 4 ,3 9a n dt h e3Q u B s( Q u e e nU n i -
versity Belfast) QuB-11b, 4156, 26 [34,35]. The length of
the PCR products and number of repeats were estimated
by eye after electrophoresis using agarose Gels 2% and a
corresponding table concordant with that of MIRU-
VNTR+ website [12].
Statistical and clustering analysis
The discriminatory powers of different typing methods
were estimated by computing the numerical index of
discrimination, the Hunter-Gaston Discriminatory Index
(HGDI), as described previously [36]. Markers with
missing data were not included for the calculation of
the HGDI. The Recent Transmission Index (RTI) was
computed using the (n-1) method [37]. Dendrogram
was drawn using the UPGMA (Unweighted Pair Group
Method using Arithmetic averages) implemented in Bio-
numerics 5.1 version software (Applied Maths, Sint-
Marten-Latems, Belgium) following the methods
described in user’s manual and with missing data coded
as “0”.
To compare the proportion of each lineage among
MDR and non-MDR strains, odds ratio were computed
in Excel
® spreadsheet files.
Additional material
Additional file 1: 43-spacers spoligotypes subdivised by extended
68-spacers spoligotyping. cf. Figure 1 for full description of all 68-
spacerssubtypes
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